Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice-Reference-Cited by-同舟云学术

Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice

Published:2015-06-29 Issue:6 Volume:10 Page:e0130605
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kashiwagi Yusuke,Nagoshi Tomohisa,Yoshino Takuya,Tanaka Toshikazu D.,Ito Keiichi,Harada Tohru,Takahashi Hiroyuki,Ikegami Masahiro,Anzawa Ryuko,Yoshimura Michihiro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Optimization of Cardiac Metabolism in Heart Failure;T Nagoshi;Curr Pharm Des,2011

2. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo;T Matsui;Circulation,2001

3. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury;T Nagoshi;J Clin Invest,2005

4. Effects of chronic Akt activation on glucose uptake in the heart;T Matsui;Am J Physiol Endocrinol Metab,2006

5. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis;R Tian;Circulation,2001

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Off-Target Cardioprotective Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors: An Overview;International Journal of Molecular Sciences;2024-07-14

2. Protective Mechanisms of SGLTi in Ischemic Heart Disease;Journal of Cardiovascular Translational Research;2024-05-20

3. Cardioprotective Effects of Sodium-Glucose Cotransporter Subtype Inhibition on Ischemic and Pharmacological Preconditioning;Cureus;2024-05-06

4. Sotagliflozin versus dapagliflozin to improve outcome of patients with diabetes and worsening heart failure: a cost per outcome analysis;Frontiers in Pharmacology;2024-04-17

5. Progenitor Cell Function and Cardiovascular Remodelling Induced by SGLT2 Inhibitors;Frontiers in Bioscience-Landmark;2024-04-09